Please sign in to follow a disease.
Butter vs. skim: which dairy is better for your heart?
NCT ID NCT07605442
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether full-fat dairy and low-fat dairy have similar effects on risk factors for heart disease and diabetes. About 178 healthy adults and those at risk will eat either low-fat or full-fat milk, yogurt, and cheese for 6 weeks each, with a break in between. Researchers will measure cholesterol, blood sugar, weight, and blood pressure to see how each type of dairy affects heart health.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 178 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Aug 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
25 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * BMI 18.5 to 39.9 kg/m2 * LDL-C ≤190 mg/dL assessed by the Modified Sampson-NIH Equation * Currently consume milk, yogurt, and/or cheese daily * Willing to eat 3 servings of dairy (milk, yogurt, cheese) for two 6-week periods during the study Exclusion Criteria: * Hemoglobin \<13.2 g/dL for men or \< 11.7 g/dL for women at screening * Fasting triglycerides \>350 mg/dL at screening * ≥10% change in body weight within the 6 months prior to enrollment * Blood pressure \>140/90 mmHg at screening * Fasting glucose ≥126 mg/dL * Type 1 or type 2 diabetes * Takes any (prescription or over-the-counter) anti-hypertensive, lipid-lowering, glucose-lowering or anti-inflammatory drugs, or drugs that alter body weight * Intake of supplements that affect the outcomes of interest (i.e., lipids, blood pressure, glucose, body weight, inflammation and microbiome) and are unwilling to cease during the study period. * Unwilling to refrain from starting to take any supplements, vitamins, nutritional products, or health foods that are not prescribed by a doctor for the duration of the study * History of liver, kidney, or autoimmune disease * Prior cardiovascular event (e.g., stroke, heart attack) * Current pregnancy or intention of pregnancy within the next 12 months * Lactation within the prior 6 months * Dairy allergy/intolerance/sensitivity/dislike * Antibiotic use within the prior four weeks * Oral steroid use within the prior four weeks * Use of tobacco or nicotine-containing products within the past 6 months * History of cancer at any site within the past 10 years (eligible if ≥10 years without recurrence) or non-melanoma skin cancer within the past 5 years (eligible if ≥5 years without recurrence) * Participation in another clinical trial within 60 days of baseline * Currently following a restricted or weight-loss diet * Prior bariatric surgery * Intake of \>14 alcoholic drinks/week and/or not willing to avoid alcohol consumption for 48 hours prior to test visits * Does not speak and/or understand English * Unwilling to refrain from donating blood and/or plasma during the study * Weight \<110 lb * Lactose intolerance or sensitivity * Unwilling to contact study staff before enrolling in other health-related research and avoid participating in any research that may interfere with this study * For individuals taking thyroid medication: abnormal thyroid stimulated hormone (TSH) concentration, or change in dose of thyroid medication within the last 6 months * Principal Investigator discretion related to the potential participant's ability to adhere to the study requirements, including being able to come to attend visits
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cardiovascular (CV) risk are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Mammograms may reveal hidden heart risk in women
- Could a health Worker's support break the smoking habit in mental illness?
- Can we predict who will change habits after a heart attack?
- Could a simple blood test flag heart risk in rheumatoid arthritis?
- Can job frustration raise your blood pressure? a new study aims to find out
- Menopause heart risk targeted by tailored exercise and diet programs